Watch for Gallbladder Problems in Patients Using GLP-1 Agonists
You'll hear more about a possible link between gallbladder disease and GLP-1 agonists...such as Victoza (liraglutide) or Byetta (exenatide).
The latest evidence suggests that about one in 357 patients on liraglutide or exenatide over about 3 years will be hospitalized for bile duct or gallbladder disease...compared to patients on other diabetes meds.
Patients with diabetes already have a higher risk of bile duct and gallbladder disease. But GLP-1 agonists may increase this risk...possibly by causing rapid weight loss in some patients.